SYNDROME D'ACTIVATION MACROPHAGIQUE CHEZ L ... - Toubkal

[58] G. JankaHemophagocytic Lymphohistiocytosis: When the Immune System Runs AmokKlin Padiatr 2009; 221: 278– 285[59] A Albert, Z Azgui, J Buisine, M Ciaudo, O FenneteauMacrophage activation syndromesNouv Rev FR Haematol, 1992 ; 34 ; 435-441.[60] Suzuki A, TakahashiT, Okuno Y, et al.Liver damage in patients with colony-stimulating factors – Producing tumors.Am J Med 1993; 94: 125-132.[61] Jones A, PJ Selby, Viner C, Hobbs S, Gore ME, McElwain TJ.Tumor necrosis factor, cholestasis and chronic liver disease.Gut 1990; 31: 938-939[62] Ott M, Vore M, Barker D, Strodel W, McClain C.Monokine depression of bile flow in the isolated perfused rat liver.J Surg Res 1989; 47: 248-250.[63] Trauner M, Meier PJ, Boyer JL.Molecular pathogenesis of cholestasis.NEJM 1998; 339: 1217-1227.[64] Vos T, Hooiveld G, Koning H, Childs S, Meijer D, Moshage H et al.Up-regulation of the multidrugs resistance genes, Mrp1 and Mdr1b, and down regulation ofthe organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxinemicrat liver.Hepatology 1998 ; 28 : 1637-1644[65] Henter JI, Elinder G, Ost A.Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL study group of theHistiocyte society.Semin Oncol 1991; 18:29–33[66] Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al.HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.Pediatr Blood Cancer 2007; 48(2):124–31.[67] S. Atmani, K. El Alaoui, R. Aouragh, A. Bouharrou, M. HidaSyndrome d’activation macrophagique associé à la leishmaniose viscérale à propos de deuxobservationsMédecine du Maghreb 2008 ; 156 : 5-8205